Thermo Fisher Scientific's proposed $13.6 billion acquisition of Life Technologies
Supported the expert working on behalf of Thermo Fisher Scientific in evaluating the likely competitive effects of its proposed $13.6 billion acquisition of Life Technologies; both firms provide analytical and laboratory services and products. Because of these firms’ global presence, multiple antitrust agencies around the world, including the Federal Trade Commission, reviewed the proposed acquisition. Performed rigorous analyses on horizontal and vertical issues related to the transaction, including a theoretical and empirical analysis of possible vertical effects based in part on a retrospective study of previous mergers. Provided consulting support regarding competition issues involved in the European and Chinese investigations of the acquisition. The transaction was approved by all the relevant competition agencies after Thermo Fisher agreed to divest three business units to General Electric Company’s health care unit.